Marimed Inc.

MRMD Biotech & pharma

Develops cannabis products for medical and adult-use customers.

Jun 2026Revenue $164M/yrExpenses $166M/yr
No trend
Figures by year

When will Marimed be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $164M and expenses $166M.

Fiscal year toRevenueExpensesOperating profit
Dec 2025$160M$163M−$2.82M
Dec 2024$158M$155M$2.61M
Dec 2023$149M$134M$14.4M
Dec 2022$134M$114M$20.4M
Dec 2021$121M$94.6M$26.9M
Dec 2020$50.9M$36.4M$14.5M
Dec 2019$45.6M$87.1M−$41.5M
Dec 2018$11.9M$17.2M−$5.36M
Dec 2017$6.07M$5.94M$128K
Dec 2016$3.56M$2.79M$775K